Phase II Study of Abemaciclib + Pembrolizumab in KRAS-Mutated, PD-L1+, Stage IV Chemonaïve Non–Small Cell Lung Cancer and in Pretreated Squamous Cell Lung Cancer.
Kongre ve sempozyumlar > Kongre · 2016
Yazarlar: Tuncay GÖKSEL
2016-2016, Phase II Study of Abemaciclib + Pembrolizumab in KRAS-Mutated, PD-L1+, Stage IV Chemonaïve Non–Small Cell Lung Cancer and in Pretreated Squamous Cell Lung Cancer., Kongre, Katılımcı, Avusturya, Vienna